February 25, 2013 – Dr. Sosa joined the DCRI in January to lead and develop an endocrine neoplasia disease program at the DCRI and the Duke Cancer Institute.
Julie Ann Sosa, MD, MA, FACS, most recently from Yale University, joined the DCRI in January to lead and develop an endocrine neoplasia disease program at the DCRI and the Duke Cancer Institute. She will be a professor in the Duke Department of Surgery, Division of Surgical Oncology, with a secondary faculty appointment in the Department of Medicine. She is the chief of Endocrine Surgery, which consists of three full time endocrine surgeons, as well as director of Health Services Research in the Department of Surgery. While at Yale, Dr. Sosa led the Clinical Research Program in Endocrine Neoplasia at the Smilow Cancer Hospital at Yale New Haven.
In her role as Chief of Endocrine Surgery, Dr. Sosa will strengthen the academic and clinical aspects of the endocrine surgery program. She will help develop strategies to increase the clinical volume and implement quality metrics within endocrine surgery at Duke. These include creating a multidisciplinary approach to endocrine neoplasia care at the cancer institute, opening clinical trials using small molecule therapies for advanced thyroid cancer, tumor banking, and extending endocrine surgery into Wake County. She will be introducing novel surgical techniques at Duke, including minimally invasive parathyroidectomy under local analgesia in the ambulatory setting and posterior retroperitoneal laparoscopic adrenalectomy. Duke will serve as one of the initial institutions participating in the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP), a national patient registry modeled after the American College of Surgeons National Surgical Quality Improvement Program that is intended to measure and standardize the quality of endocrine surgery care in the U.S.
Within the DCRI, Dr. Sosa will focus on her specific research interests in endocrine surgery, stem cell research, and thyroid cancer, while developing opportunities and potential partnerships for the new endocrine research program. She is anxious to facilitate training of medical students, surgical residents and fellows in health services research, organize faculty members and their mentees interested in HSR across surgical divisions and specialties to participate in a regular research–in-progress platform, and to find areas for collaboration between Duke Surgery and the DCRI.
Dr. Sosa earned her undergraduate degree from the Woodrow Wilson School at Princeton University and her MD from John Hopkins University School of Medicine, where she also completed the Halsted residency program and a fellowship. She was a Robert Wood Johnson Clinical Scholar, also at Johns Hopkins. She received her master’s degree from the University of Oxford. She is a member of the International Thyroid Oncology Group and is widely published in outcomes, education, and survey-based research, as well as meta-analysis and cost-effectiveness analyses, with more than 130 peer-reviewed publications. She has received funding from the Paget Foundation, the Donaghue Foundation, the Association for Academic Surgery, the American Geriatrics Society/Hartford Foundation, and the Connecticut Stem Cell Research Fund. She has been a principal investigator for numerous trials for advanced thyroid cancer. Dr. Sosa is associate editor of the Journal of Surgical Research and is on the editorial boards of the Journal of Clinical Endocrinology and Metabolism and the Journal of Thyroid Research, and she is the editor of the endocrine tumors section of Current Opinion in Oncology.